Library Header Image
LSE Research Online LSE Library Services

Modelling the impact on avoidable cardiovascular disease burden and costs of interventions to lower SBP in the England population

Dodhia, Hiten, Phillips, Karen, Zannou, Maria-Irini, Airoldi, Mara and Bevan, Gwyn ORCID: 0000-0003-2123-3770 (2012) Modelling the impact on avoidable cardiovascular disease burden and costs of interventions to lower SBP in the England population. Journal of Hypertension, 30 (1). pp. 217-226. ISSN 0263-6352

Full text not available from this repository.
Identification Number: 10.1097/HJH.0b013e32834d86ee


Background: The burden of disease from cardiovascular disease (CVD) remains significant in England. Blood pressure remains an important risk factor. Health gain through public health measures and improving treatment compliance are potentially likely to be high. We assess the impact of known cost-effective interventions in terms of the avoidable CVD burden and costs by comparing these strategies to the current situation. Methods: We modelled avoidable CVD outcomes simulating the English population aged over 16 years with Excel spreadsheets for the current prevention/treatment and following various interventions over a 10-year time frame. The outcome measures were avoidable incident heart disease and stroke events, deaths and disability-adjusted life years (DALYs). Costs are reported from the health service perspective. We analysed relative cost-effectiveness, undertook sensitivity analysis and measured relative impacts of different strategies on avoidable burden of disease. Results: The assessed interventions have a potential to reduce the current burden of disease between 70 000 and about 1 million DALYs over the 10-year frame. Although all interventions were cost-effective, some (e.g. Salt reduction in the population and 'Dietary Approaches to Stop Hypertension-sodium', which modelled the impact of salt reduction and dietary approaches) were cost-saving. The cost-effectiveness of treatment strategies was sensitive to drug costs. Conclusion: Evidence-based interventions appropriately scaled up for both prevention and treatment of blood pressure lead to important additional potential health gains. There was noticeable variance in cost-effectiveness and impact among the different interventions at a population level. Taking into account impact, priority should be given to prevention to reduce blood pressure at a population level through reduced salt consumption.

Item Type: Article
Official URL:
Additional Information: © 2012 Lippincott Williams & Wilkins
Divisions: Management
Centre for Analysis of Risk & Regulation
LSE Health
Subjects: H Social Sciences > H Social Sciences (General)
R Medicine > RA Public aspects of medicine
Date Deposited: 06 Jan 2012 10:16
Last Modified: 01 Jun 2024 03:03

Actions (login required)

View Item View Item